drugset
drugset / Trial / NCT02319668

Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity

NCT02319668 ↗

Phase 4 Completed 38 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindPrevention

Summary

The primary objective of this study will be to evaluate the effect of two week pre-surgical rinsing with an antimicrobial mouthrinse containing 0.2% w/v Chlorhexidine digluconate on the total number of plaque bacteria in the mouth 3 days post implant surgery. The study will be conducted at Eastman Clinical Investigation Centre (ECIC), University College London (UCL) Eastman Dental Institute. Participants will be those who require a single and simple surgical implant to be placed, and will be recruited from new patient referrals within the Eastman Dental Hospital

Timeline

Start
2015-02-01
Primary completion
2015-06-01
Completion
2016-02-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 0.2 % Other
Background sodium fluoride Unknown — Other

Indications

No indication recorded.